3 recruiting. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 1 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow T1D: new trials by email Literature Review of T1D trials Research Report on T1D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar Tirzepatide, Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM), Carbohydrate Counting - Type 1 Diabetes, Type 1 Diabetes Mellitus | Phase 2 / Phase 3 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 105 | 2026-05-19 | 2026-05-27 |
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus OPF-310 - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Recruiting | Otsuka Pharmaceutical Factory, Inc. | 13 | 2025-06-10 | 2026-08-21 |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) CNP-103, Placebo - Type 1 Diabetes Mellitus, T1D | Phase 1 / Phase 2 | Recruiting | COUR Pharmaceutical Development Company, Inc. | 72 | 2025-05-12 | 2026-09-11 |
Diabetes Mellitus, Type 1 (3) · Diabetes Mellitus (2) · Autoimmune Diseases (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Immune System Diseases (1) · Metabolic Diseases (1) · Overweight (1)
Endocrine System Diseases (3) · Nutritional and Metabolic Diseases (3) · Autoimmune Diseases (2) · Glucose Metabolism Disorders (2) · Immune System Diseases (2) · Metabolic Diseases (2) · Body Weight (1) · Diabetes Mellitus (1) · Nutrition Disorders (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Therapeutics (1) · Tirzepatide (1)
COUR Pharmaceutical Development Company, Inc. (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Otsuka Pharmaceutical Factory, Inc. (1)
United States (2) · Canada (1) · Switzerland (1)
Ahmad Haidar, PhD (1) · Melissa-Rosina Pasqua, MD, PhD (1) · Paul Peloso, MD (1)